Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 2/2017

01-04-2017 | Review Article

The sesquiterpene α-bisabolol in the adipocyte−cancer desmoplastic crosstalk: does it have an action on epithelial−mesenchymal transition mechanisms?

Authors: Salvatore Chirumbolo, Geir Bjørklund

Published in: International Journal of Clinical Oncology | Issue 2/2017

Login to get access

Abstract

Alpha-bisabolol is a plant-derived sesquiterpene alcohol recently associated with a supposed anti-cancer action due to its ability to induce BID-related apoptosis. The molecule, which enters the cell through lipid rafts, may also interact with kisspeptin receptor 1, which has recently been associated with tumor mobility and invasiveness. This evidence suggests the possibility that α-bisabolol might act on the epithelial−mesenchymal transition mechanism, closely associated with the desmoplastic reaction of adipose tissue surrounding a pancreatic ductal adenocarcinoma. This review addresses the issue on the basis of the most recent reported literature in the field.
Literature
1.
Bhatia SP, McGinty D, Letizia CS et al (2008) Fragrance material review on alpha-bisabolol. Food Chem Toxicol 46(S11):S72–S76CrossRefPubMed
2.
Orav A, Raal A, Arak E (2010) Content and composition of the essential oil of Chamomilla recutita (L.) Rauschert from some European countries. Nat Prod Res 24(1):48–55CrossRefPubMed
3.
Presibella MM, De Biaggi C, da Silva Belletti KM et al (2006) Comparison of chemical constituents of Chamomilla recutita (L.) Rauschert essential oil and its anti-chemotactic activity. Braz Arch Biol Technol 49(5):717–724CrossRef
4.
Tolouee M, Alinezhad S, Saberi R et al (2010) Effect of Matricaria chamomilla L. flower essential oil on the growth and ultrastructure of Aspergillus niger van Tieghem. Int J Food Microbiol 139(3):127–133CrossRefPubMed
5.
Uno M, Kokuryo T, Yokoyama Y et al (2016) α-Bisabolol inhibits invasiveness and motility in pancreatic cancer through KISS1R activation. Anticancer Res 36(2):583–589PubMed
6.
Song GQ, Zhao Y (2015) Kisspeptin-10 inhibits the migration of breast cancer cells by regulating epithelial-mesenchymal transition. Oncol Rep 33(2):669–674PubMed
7.
Bochet L, Lehuédé C, Dauvillier S et al (2013) Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer. Cancer Res 73(18):5657–5668CrossRefPubMed
8.
Zoico E, Darra E, Rizzatti V, Budui S, Franceschetti G, Mazzali G, Rossi AP, Fantin F, Menegazzi M, Cinti S, Zamboni M (2016) Adipocytes Wnt5a mediated dedifferentiation: a possible target in pancreatic cancer microenvironment. Oncotarget 7(15):20223–20235PubMedPubMedCentral
9.
An J, Lv J, Li A, Qiao J, Fang L, Li Z, Li B, Zhao W, Chen H, Wang L (2015) Constitutive expression of Bcl-2 induces epithelial-Mesenchymal transition in mammary epithelial cells. BMC Cancer 15:476CrossRefPubMedPubMedCentral
10.
Darra E, Abdel-Azeim S, Manara A (2008) Insight into the apoptosis-inducing action of alpha-bisabolol towards malignant tumor cells: involvement of lipid rafts and Bid. Arch Biochem Biophys 476(2):113–123CrossRefPubMed
11.
12.
Liang Y, Liu HH, Chen YJ et al (2014) Antitumor activity of the protein and small molecule component fractions from Agrocybe aegerita through enhancement of cytokine production. J Med Food 17(4):439–446CrossRefPubMed
13.
Lee Y, Jung WH, Koo JS (2015) Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells. Breast Cancer Res Treat 153(2):323–335CrossRefPubMed
14.
Zoico E, Darra E et al (2006) Adipocytes Wnt5a mediated dedifferentiation: a possible target in pancreatic cancer microenvironment. Oncotarget. doi:10.​18632/​oncotarget.​7936 (in press)
15.
Tang L, Zhu H, Yang X, Xie F, Peng J, Jiang D, Xie J, Qi M, Yu L (2016) Shizukaol D, a Dimeric Sesquiterpene Isolated from Chloranthus serratus, represses the growth of human liver cancer cells by modulating Wnt signalling pathway. PLoS One 11(3):e0152012CrossRefPubMedPubMedCentral
16.
Yeo SK, Ali AY, Hayward OA et al (2016) β-Bisabolene, a sesquiterpene from the essential oil extract of opoponax (Commiphora guidottii), exhibits cytotoxicity in breast cancer cell lines. Phytother Res 30(3):418–425CrossRefPubMed
17.
Chirumbolo S (2015) Alpha-bisabolol, not a matter for cancer therapy. Commentary: “Research on the immunosuppressive activity of ingredients contained in sunscreens”. Front Pharmacol 6:96CrossRefPubMedPubMedCentral
18.
Cavalieri E, Bergamini C, Mariotto S et al (2009) Involvement of mitochondrial permeability transition pore opening in α-bisabolol induced apoptosis. FEBS J 276(15):3990–4000CrossRefPubMed
19.
Bulteau AL, Bayot A (2011) Mitochondrial proteases and cancer. Biochim Biophys Acta 1807(86):595–601CrossRefPubMed
20.
Pinti M, Gibellini L, Liu Y et al (2015) Lon protease at the crossroads of oxidative stress, ageing and cancer. Cell Mol Life Sci 72(24):4807–4824CrossRefPubMed
21.
Hamzeloo-Moghadam M, Aghaei M, Fallahian F et al (2015) Britannin, a sesquiterpene lactone, inhibits proliferation and induces apoptosis through the mitochondrial signaling pathway in human breast cancer cells. Tumour Biol 38(2):1191–1198CrossRef
22.
Hua P, Zhang G, Zhang Y et al (2016) Costunolide induces G1/S phase arrest and activates mitochondrial-mediated apoptotic pathways in SK-MES 1 human lung squamous carcinoma cells. Oncol Lett 11(4):2780–2786PubMedPubMedCentral
23.
Chan ML, Liang JW, Hsu LC et al (2015) Zerumbone, a ginger sesquiterpene, induces apoptosis and autophagy in human hormone-refractory prostate cancers through tubulin binding and crosstalk between endoplasmic reticulum stress and mitochondrial insult. Naunyn Schmiedebergs Arch Pharmacol 388(11):1223–1236CrossRefPubMed
24.
Zhang S, Won YK, Ong CN et al (2005) Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms. Curr Med Chem Anticancer Agents 5(3):239–249CrossRefPubMed
25.
Gach K, Długosz A, Janecka A (2015) The role of oxidative stress in anticancer activity of sesquiterpene lactones. Naunyn Schmiedebergs Arch Pharmacol 388(5):477–486CrossRefPubMed
26.
Cha YH, Yook JI, Kim HS et al (2015) Catabolic metabolism during cancer EMT. Arch Pharm Res 38(3):313–320CrossRefPubMed
27.
Lu J, Tan M, Cai Q (2015) The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett 356(2 Pt A):156–164CrossRefPubMed
28.
Liu W, Beck BH, Vaidya KS et al (2014) Metastasis suppressor KISS1 seems to reverse the Warburg effect by enhancing mitochondrial biogenesis. Cancer Res 74(3):954–963CrossRefPubMed
29.
30.
Kochhar S, Martin FP (2015) Gut microbiota metabolism in nutrition, health and disease in “Metabolomics and gut microbiota in nutrition and disease”. Humana Press, Heidelberg, pp 261–298
31.
Bode AM, Dong Z (2015) Toxic phytochemicals and their potential risks for human cancer. Cancer Prev Res (Phila) 8(1):1–8CrossRef
32.
Castelli MV, Lodeyro AP, Malheiros A et al (2005) Inhibition of the mitochondrial ATP synthesis by polygodial, a naturally occurring dialdehyde unsaturated sesquiterpene. Biochem Pharmacol 70(1):82–89CrossRefPubMed
33.
34.
Leslie EM, Mao Q, Oleschuk CJ et al (2001) Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids. Mol Pharmacol 59(5):1171–1180PubMed
35.
Wictome M, Starling AP, Sharma RP et al (1993) Inhibition of the Ca(2+)-ATPase by sesquiterpene lactones. Biochem Soc Trans 21(4):348SCrossRefPubMed
36.
Lamb R, Bonuccelli G, Ozsvári B et al (2015) Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: understanding WNT/FGF-driven anabolic signaling. Oncotarget 6(31):30453–30471PubMedPubMedCentral
37.
Proksch S, Steinberg T, Stampf S et al (2012) Crosstalk on cell behavior in interactive cocultures of hMSCs with various oral cell types. Tissue Eng Part A 18(23):2601–2610CrossRefPubMed
38.
Shimizu Y, Sato S (2015) In vitro study on regeneration of periodontal tissue microvasculature using human dedifferentiated fat cells. J Periodontol 86(1):129–136CrossRefPubMed
39.
Jeong HJ, Park SW, Kim H et al (2010) Coculture with BJ fibroblast cells inhibits the adipogenesis and lipogenesis in 3T3-L1 cells. Biochem Biophys Res Commun 392(4):520–525CrossRefPubMed
40.
Hsia LT, Ashley N, Ouaret D et al (2016) Myofibroblasts are distinguished from activated skin fibroblasts by the expression of AOC3 and other associated markers. Proc Natl Acad Sci USA 113(15):E2162–E2171CrossRefPubMedPubMedCentral
41.
Kou L, Lu XW, Wu MK et al (2014) The phenotype and tissue-specific nature of multipotent cells derived from human mature adipocytes. Biochem Biophys Res Commun 444(4):543–548CrossRefPubMed
42.
Kim IH, Kim SW, Kim SH et al (2012) Parthenolide-induced apoptosis of hepatic stellate cells and anti-fibrotic effects in an in vivo rat model. Exp Mol Med 44(7):448–456CrossRefPubMedPubMedCentral
43.
Cui B, Zhang S, Chen L et al (2013) Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis. Cancer Res 73(12):3649–3660CrossRefPubMed
44.
Matsuyama M, Nomori A, Nakakuni K et al (2014) Secreted Frizzled-related protein 1 (Sfrp1) regulates the progression of renal fibrosis in a mouse model of obstructive nephropathy. J Biol Chem 289(45):31526–31533CrossRefPubMedPubMedCentral
45.
Wang R, Hong J, Liu R et al (2014) SFRP5 acts as a mature adipocyte marker but not as a regulator in adipogenesis. J Mol Endocrinol 53(3):405–415CrossRefPubMed
46.
Negmadjanov U, Godic Z, Rizvi F et al (2015) TGF-β1-mediated differentiation of fibroblasts is associated with increased mitochondrial content and cellular respiration. PLoS One 10(4):e0123046CrossRefPubMedPubMedCentral
47.
Jabeen S, Qureshi MZ, Javed Z et al (2016) Kisspeptin mediated signaling in cancer. Curr Top Med Chem 16(22):2471–2476CrossRefPubMed
48.
49.
50.
Huma T, Wang Z, Rizak J et al (2013) Kisspeptin-10 modulates the proliferation and differentiation of the rhesus monkey derived stem cell line: R366.4. Sci World J 2013:135470CrossRef
51.
Darra E, Lenaz G, Cavalieri E et al (2007) Alpha-bisabolol: unexpected plant-derived weapon in the struggle against tumour survival? Ital J Biochem 56(4):323–328PubMed
52.
Chen W, Hou J, Yin Y et al (2010) Alpha-Bisabolol induces dose- and time-dependent apoptosis in HepG2 cells via a Fas- and mitochondrial-related pathway, involves p53 and NFkappaB. Biochem Pharmacol 80(2):247–254CrossRefPubMed
53.
Kumar M, Allison DF, Baranova NN et al (2013) NF-κB regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells. PLoS One 8(7):e68597CrossRefPubMedPubMedCentral
54.
Chirumbolo S, Bjørklund G (2016) Can Wnt5a and Wnt non-canonical pathways really mediate adipocyte de-differentiation in a tumour microenvironment? Eur J Cancer 64:96–100CrossRefPubMed
55.
Golzar F, Javanmard SH, Bahrambeigi V et al (2015) The effect of Kisspeptin-10 on mesenchymal stem cells migration in vitro and in vivo. Adv Biomed Res 4:20CrossRefPubMedPubMedCentral
56.
57.
Satoh K, Hamada S, Shimosegawa T (2015) T. Involvement of epithelial to mesenchymal transition in the development of pancreatic ductal adenocarcinoma. J Gastroenterol 50(2):140–146CrossRefPubMed
58.
Ji K, Ye L, Ruge F, Hargest R et al (2014) Implication of metastasis suppressor gene, Kiss-1 and its receptor Kiss-1R in colorectal cancer. BMC Cancer 14:723CrossRefPubMedPubMedCentral
59.
Ji K, Ye L, Mason MD et al (2013) The Kiss-1/Kiss-1R complex as a negative regulator of cell motility and cancer metastasis (review). Int J Mol Med 32(4):747–754PubMed
60.
Tian L, Lu ZP, Cai BB et al (2016) Activation of pancreatic stellate cells involves an EMT-like process. Int J Oncol 48(29):783–792PubMed
61.
Bubici C, Papa S, Pham CG et al (2006) The NF-kappaB-mediated control of ROS and JNK signaling. Histol Histopathol 21(1):69–80PubMed
62.
Kim S, Jung E, Kim JH et al (2011) D. Inhibitory effects of (-)-α-bisabolol on LPS-induced inflammatory response in RAW264.7 macrophages. Food Chem Toxicol 49(10):2580–2585CrossRefPubMed
63.
Jing YY, Han ZP, Sun K et al (2012) Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide. BMC Med 10:98CrossRefPubMedPubMedCentral
64.
Li H, Li Y, Liu D et al (2014) LPS promotes epithelial-mesenchymal transition and activation of TLR4/JNK signaling. Tumour Biol 35(10):10429–10435CrossRefPubMed
65.
Chirumbolo S, Franceschetti G, Zoico E et al (2014) LPS response pattern of inflammatory adipokines in an in vitro 3T3-L1 murine adipocyte model. Inflamm Res 63(6):495–507CrossRefPubMed
66.
Chirumbolo S, Rossi AP, Rizzatti V et al (2015) Iron primes 3T3-L1 adipocytes to a TLR4-mediated inflammatory response. Nutrition 31(10):1266–1274CrossRefPubMed
67.
Wu Y, Tang L (2016) Bcl-2 family proteins regulate apoptosis and epithelial to mesenchymal transition by calcium signals. Curr Pharm Des 22(30):4700–4704CrossRefPubMed
68.
Smaili SS, Hsu YT, Youle RJ et al (2000) Mitochondria in Ca2+ signaling and apoptosis. J Bioenerg Biomembr 32(1):35–46CrossRefPubMed
69.
Ouyang F, Huang H, Zhang M et al (2016) HMGB1 induces apoptosis and EMT in association with increased autophagy following H/R injury in cardiomyocytes. Int J Mol Med 37(3):679–689PubMedPubMedCentral
70.
Magnelli L, Caldini R, Schiavone N et al (2010) Differentiating and apoptotic dose-dependent effects in (−)-alpha-bisabolol-treated human endothelial cells. J Nat Prod 73(4):523–526CrossRefPubMed
Metadata
Title
The sesquiterpene α-bisabolol in the adipocyte−cancer desmoplastic crosstalk: does it have an action on epithelial−mesenchymal transition mechanisms?
Authors
Salvatore Chirumbolo
Geir Bjørklund
Publication date
01-04-2017
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 2/2017
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-016-1072-z

Other articles of this Issue 2/2017

International Journal of Clinical Oncology 2/2017 Go to the issue

Original Article

Combined antitumor effect of γ-secretase inhibitor and ABT-737 in Notch-expressing non-small cell lung cancer

Original Article

Risk scores as useful predictors of perioperative complications in patients with rectal cancer who received radical surgery

Original Article

Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers

Original Article

Incidence of hypophosphatemia in advanced cancer patients: a recent report from a single institution

Original Article

Feasibility of adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent maintenance therapy with S-1 for completely resected non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 1001

Invited Review Article

Recent progress and perspectives on prostate cancer biomarkers
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits